Aytu Biopharma, Inc financial data

Symbol
AYTU on Nasdaq
Industry
Pharmaceutical Preparations
Location
7900 E. Union Avenue, Suite 920, Denver, CO
State of incorporation
DE
Fiscal year end
June 30
Former names
AYTU BIOSCIENCE, INC (to 3/22/2021), Rosewind CORP (to 6/8/2015)
Latest financial report
10-K - Q2 2024 - Sep 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 101 % +3.7%
Quick Ratio 18.8 % +7.68%
Debt-to-equity 253 % +55.6%
Return On Equity -61.9 % +51.5%
Return On Assets -12.4 % -4.55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.15M shares +11.2%
Common Stock, Shares, Outstanding 5.97M shares +8.26%
Entity Public Float 10.7M USD -12.9%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.54M shares +65.8%
Weighted Average Number of Shares Outstanding, Diluted 5.48M shares +118%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 81M USD -24.6%
Cost of Revenue 41.2M USD -6.27%
Research and Development Expense 2.79M USD -31.8%
Selling and Marketing Expense 27M USD -35%
General and Administrative Expense 22.5M USD -21.4%
Operating Income (Loss) -5.25M USD +69.2%
Nonoperating Income (Expense) -7.71M USD -424%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.1M USD +17.4%
Income Tax Expense (Benefit) 245K USD
Net Income (Loss) Attributable to Parent -15.8M USD +7.08%
Earnings Per Share, Basic -2.86 USD/shares +44%
Earnings Per Share, Diluted -6.31 USD/shares +88%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20M USD -13%
Accounts Receivable, after Allowance for Credit Loss, Current 23.6M USD -18.4%
Inventory, Net 12.6M USD +5.32%
Other Assets, Current 61.9M USD -12.9%
Assets, Current 71.1M USD -9.35%
Property, Plant and Equipment, Net 693K USD -61.8%
Operating Lease, Right-of-Use Asset 829K USD -59.6%
Intangible Assets, Net (Excluding Goodwill) 52.5M USD -11.1%
Goodwill 0 USD
Other Assets, Noncurrent 2.23M USD -12.4%
Assets 118M USD -13.5%
Accounts Payable, Current 10.4M USD -22.5%
Employee-related Liabilities, Current 4.94M USD -13%
Accrued Liabilities, Current 38.6M USD -17.6%
Contract with Customer, Liability, Current 100K USD -50%
Liabilities, Current 62.2M USD -9.83%
Long-term Debt and Lease Obligation 10.9M USD -26.1%
Operating Lease, Liability, Noncurrent 577K USD -30.6%
Other Liabilities, Noncurrent 4.53M USD -35.1%
Liabilities 101M USD -0.92%
Retained Earnings (Accumulated Deficit) -320M USD -5.21%
Stockholders' Equity Attributable to Parent 27.7M USD -29.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 32.2M USD -33.5%
Liabilities and Equity 118M USD -13.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -211K USD +97.7%
Net Cash Provided by (Used in) Financing Activities -2.73M USD -120%
Net Cash Provided by (Used in) Investing Activities -76K USD -281%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.97M shares +8.26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.02M USD -168%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.8M USD +3.24%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.36M USD +141%
Deferred Tax Assets, Valuation Allowance 137M USD +0.95%
Deferred Tax Assets, Gross 138M USD +0.5%
Operating Lease, Liability 1.29M USD -38.3%
Depreciation 900K USD -30.8%
Lessee, Operating Lease, Liability, to be Paid 2.2M USD -16.1%
Property, Plant and Equipment, Gross 2.82M USD -48.7%
Operating Lease, Liability, Current 712K USD -43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 399K USD -46.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 970K USD -29.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +25.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 555K USD +221%
Lessee, Operating Lease, Liability, to be Paid, Year Three 377K USD +319%
Deferred Tax Assets, Operating Loss Carryforwards 119M USD +4.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 1.31M USD -55.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 386K USD +739%
Operating Lease, Payments 360K USD +0.84%
Additional Paid in Capital 348M USD +1.22%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.21M USD +8.86%
Depreciation, Depletion and Amortization 2.23M USD -3.09%
Deferred Tax Assets, Net of Valuation Allowance 762K USD -44.7%
Share-based Payment Arrangement, Expense 2.91M USD -51.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%